Skip to content
ChickenStockChickenStock
ResearchEW
Edwards Lifesciences logo

Edwards Lifesciences (EW) stock

NYSE

$107.15+1.28%(+1.35)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

60.23x

P/B

5.67x

P/S

9.23x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 10.5% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 4, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

30 SEC filings
  • Dahl Andrew M.SVP, Corporate Controller · Nov 13, 2026Shares withheld for taxes101 shares · $11K
    Avg. price $105.814,606 shares held after
  • Lippis Daniel J.CVP, TAVR · Nov 10, 2026Open-market sale619 shares · $65K
    Avg. price $104.2540,034 shares held after
  • Lippis Daniel J.CVP, TAVR · Nov 10, 2026Option exercise619 shares · $45K
    Avg. price $72.6840,653 shares held after
  • BOBO DONALD E JRCVP,Strategy/Corp Development · Nov 9, 2026Open-market sale48,900 shares · $5.0M
    Avg. price $103.053422,798 shares held after
  • Zovighian Bernard JCEO · Nov 9, 2026Open-market sale23,100 shares · $2.4M
    Avg. price $103.0208
    Show 2 price lots
    • 13,916 shares × $102.7803$1.4M
    • 9,184 shares × $103.3851$949K
  • BOBO DONALD E JRCVP,Strategy/Corp Development · Nov 9, 2026Option exercise48,900 shares · $3.6M
    Avg. price $72.6871,698 shares held after
  • Zovighian Bernard JCEO · Nov 9, 2026Option exercise23,100 shares · $1.7M
    Avg. price $72.68121,945 shares held after
  • Lippis Daniel J.CVP, TAVR · Oct 8, 2026Open-market sale619 shares · $53K
    Avg. price $85.6540,034 shares held after
  • Lippis Daniel J.CVP, TAVR · Oct 8, 2026Option exercise619 shares · $45K
    Avg. price $72.6840,653 shares held after
  • Markowitz WayneCVP, JAPAC · Sep 14, 2026Shares withheld for taxes568 shares · $48K
    Avg. price $84.3719,371 shares held after
  • Dahl Andrew M.SVP, Corporate Controller · Sep 13, 2026Shares withheld for taxes253 shares · $21K
    Avg. price $84.3714,615 shares held after
  • Lippis Daniel J.CVP, TAVR · Sep 11, 2026Open-market sale619 shares · $54K
    Avg. price $87.5140,034 shares held after
  • Lippis Daniel J.CVP, TAVR · Sep 11, 2026Option exercise619 shares · $45K
    Avg. price $72.6840,653 shares held after
  • Chopra DaveenCVP, TMTT, Surgical & IHFM · Sep 11, 2026Shares withheld for taxes398 shares · $35K
    Avg. price $86.7743,926 shares held after
  • Markowitz WayneCVP, JAPAC · Sep 11, 2026Shares withheld for taxes355 shares · $31K
    Avg. price $86.7719,939 shares held after
  • Dahl Andrew M.SVP, Corporate Controller · Aug 31, 2026Open-market sale544 shares · $50K
    Avg. price $91.05514,868 shares held after
  • Bruls AnnetteCVP, EMEACLA · Aug 28, 2026Open-market sale2,644 shares · $238K
    Avg. price $89.9817,984 shares held after
  • Chopra DaveenCVP, TMTT, Surgical & IHFM · Aug 26, 2026Open-market sale31,800 shares · $2.9M
    Avg. price $91.0201
    Show 2 price lots
    • 30,646 shares × $90.9922$2.8M
    • 1,154 shares × $91.7614$106K
  • Markowitz WayneCVP, JAPAC · Aug 26, 2026Open-market sale1,240 shares · $113K
    Avg. price $91.46520,294 shares held after
  • Chopra DaveenCVP, TMTT, Surgical & IHFM · Aug 26, 2026Option exercise31,800 shares · $2.3M
    Avg. price $72.6876,124 shares held after
  • Lippis Daniel J.CVP, TAVR · Aug 11, 2026Open-market sale619 shares · $57K
    Avg. price $92.0340,034 shares held after
  • Lippis Daniel J.CVP, TAVR · Aug 11, 2026Option exercise619 shares · $45K
    Avg. price $72.6840,653 shares held after
  • Markowitz WayneCVP, JAPAC · Jul 30, 2026Open-market sale146 shares · $13K
    Avg. price $86.033821,534 shares held after
  • Markowitz WayneCVP, JAPAC · Jul 28, 2026Open-market sale9,628 shares · $819K
    Avg. price $85.0621,680 shares held after
  • Markowitz WayneCVP, JAPAC · Jul 28, 2026Option exercise9,628 shares · $713K
    Avg. price $74.0231,308 shares held after
  • Zovighian Bernard JCEO · Jul 27, 2026Open-market sale2,921 shares · $245K
    Avg. price $83.93428,916 shares held after
  • Zovighian Bernard JCEO · Jul 27, 2026Gift639 shares · $0
    Avg. price $0
    Show 2 price lots
    • 320 shares × $0$0
    • 320 shares × $0$0

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Edwards Lifesciences (EW) stock information

NYSE

Edwards Lifesciences (EW) is listed on NYSE. Its market capitalization is about $61.6B. On trailing-twelve-month earnings the P/E ratio is 60.23, and the P/B ratio is 5.67. Return on equity is 9.4%. These figures are computed in-house from official filings and are reference information only.

Edwards Lifesciences — frequently asked questions

What is the P/E ratio of Edwards Lifesciences (EW)?
On a trailing-twelve-month basis, EW trades at a P/E ratio of 60.23. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Edwards Lifesciences?
EW has a market capitalization of about $61.6B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.